Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-18-028925
Date:2018-11-09
Issuer: AERPIO PHARMACEUTICALS, INC. (ARPO)
Original Submission Date:

Reporting Person:

HOFFMAN STEPHEN J
C/O AERPIO PHARMACEUTICALS, INC.
9987 CARVER ROAD, SUITE 420 CINCINNATI, OH 45242

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2018-11-09 P 1,967 a $1.95 1,967 direct
COMMON STOCK 2018-11-12 P 30,000 a $2.01 31,967 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the price reported in column 4 is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $1.95 to $2.05, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff at the securities and exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
WhaleWisdom Logo

Elevate your investments